Abiopharma

CROCS, INC. (CROX)

Symbol	CROX
Name	CROCS, INC.
Sector	CONSUMER DISCRETIONARY
Region	North America
Industry	Shoe Manufacturing
Address	13601 VIA VARRA, BROOMFIELD, Colorado, 80020, United States
Telephone	+1 303 848-7000
Fax	—
Email	—
Website	https://www.crocs.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001334036
Description	Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. Additional info from NASDAQ: Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children.

2026-05-06 10:40

New Form SCHEDULE 13G - Crocs, Inc. Filed: 2026-05-06 AccNo: 0002000043-26-000004 Size: 6 KB

2026-04-30 18:32

CROCS, INC. (CROX) Files Form 10-Q

2026-04-30 11:06

(30% Negative) CROCS, INC. (CROX) Reports Q2 2026 Financial Results

2026-04-30 11:00

Crocs, Inc. Reports Better-Than-Expected First Quarter 2026 Results And Raises Full-Year Outlook

2026-04-29 18:53

New Form SCHEDULE 13G - Crocs, Inc. Filed: 2026-04-29 AccNo: 0002100119-26-000367 Size: 7 KB

2026-04-09 11:30

Crocs, Inc. Announces Conference Call to Review First Quarter 2026 Earnings Results

2026-03-26 18:43

New Form SCHEDULE 13G/A - Crocs, Inc. Filed: 2026-03-26 AccNo: 0000102909-26-001084 Size: 7 KB

2026-03-24 20:19

REAGAN PATRAIC 🔴 sold 3.5K shares of Crocs, Inc. (CROX) at $79.69 Transaction Date: Mar 22, 2026 | Filing ID: 000004